Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Relay Therapeutics files to sell up to $213 million more shares via TD CowenAug 6FinancingRelay Therapeutics, Inc.
Relay Therapeutics amends ATM deal, adds legal opinion and Q2 results in same filingAug 6Quarterly updateRelay Therapeutics, Inc.